3 not yet recruiting. 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Not yet recruiting 3 |
| Phase 3 | 1 | Not yet recruiting 1 |
Follow Arteritis: new trials by email Literature Review of Arteritis trials Research Report on Arteritis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Reducing Arterial Inflammation Using Eplerenone and Statins in HIV Eplerenone, Placebo - HIV (Human Immunodeficiency Virus), Cardiovascular Diseases (CVD) | Phase 2 / Phase 3 | Not yet recruiting | Massachusetts General Hospital | 124 | 2027-03-01 | 2026-10-23 |
| Bosentan in the Treatment of Giant Cell Arteritis Bosentan, Glucocorticoids - Giant Cell Arteritis (GCA) | Phase 2 | Not yet recruiting | Assistance Publique - Hôpitaux de Paris | 40 | 2026-06-01 | 2026-05-06 |
| Phase II Interventional Study Evaluating Efficacy and Safety of Secukinumab in Active Severe Takayasu Patients Secukinumab, Standard of Care (SOC) - Takayasu Arteritis, Large Vessel Vasculitis | Phase 2 | Not yet recruiting | Assistance Publique - Hôpitaux de Paris | 52 | 2026-04-01 | 2026-03-27 |
Acquired Immunodeficiency Syndrome (1) · Cardiovascular Diseases (1) · Giant Cell Arteritis (1) · Heart Diseases (1) · Takayasu Arteritis (1)
Vascular Diseases (3) · Vasculitis (3) · Cardiovascular Diseases (2) · Immune System Diseases (2) · Skin Diseases (2) · Skin Diseases, Vascular (2) · Skin and Connective Tissue Diseases (2) · Aortic Arch Syndromes (1) · Aortic Diseases (1) · Autoimmune Diseases (1) · Autoimmune Diseases of the Nervous System (1) · Blood-Borne Infections (1) · Brain Diseases (1) · Central Nervous System Diseases (1)
Bosentan (1) · Eplerenone (1) · Glucocorticoids (1) · Standard of Care (1) · secukinumab (1)
Assistance Publique - Hôpitaux de Paris (2) · Massachusetts General Hospital (1)
France (1) · United States (1)